| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
reversion inducing cysteine rich protein with kazal motifs | 0.547 | 0.731 | 1.9E-10 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.200 | None | 0.952 | 2 | 0 | 2003 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.140 | None | 1.000 | 1 | 0 | 2006 | 2015 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.120 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
bone morphogenetic protein receptor type 1A | 0.522 | 0.731 | 0.90 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
group | 0.100 | None | 1.000 | 5 | 0 | 1994 | 2018 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
group | 0.100 | None | 1.000 | 4 | 0 | 1995 | 2018 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 1983 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.080 | None | 1.000 | 5 | 0 | 2002 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.070 | None | 0.714 | 4 | 0 | 1994 | 2008 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.070 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
group | 0.060 | None | 1.000 | 5 | 0 | 2004 | 2015 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.060 | None | 1.000 | 4 | 0 | 2002 | 2019 | ||||||||
|
cholecystokinin B receptor | 0.573 | 0.615 | 2.1E-06 |
|
group | 0.060 | None | 1.000 | 4 | 0 | 1997 | 2009 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
group | 0.060 | None | 1.000 | 3 | 0 | 1997 | 2007 | ||||||||
|
15-hydroxyprostaglandin dehydrogenase | 0.516 | 0.731 | 1.4E-05 |
|
group | 0.060 | None | 1.000 | 2 | 0 | 2004 | 2014 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.060 | None | 1.000 | 1 | 0 | 1985 | 2011 | ||||||||
|
mitogen-activated protein kinase 8 | 0.397 | 0.885 | 1.00 |
|
group | 0.050 | None | 1.000 | 4 | 0 | 2005 | 2015 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
group | 0.050 | None | 1.000 | 3 | 0 | 2000 | 2015 | ||||||||
|
Kruppel like factor 4 | 0.449 | 0.769 | 1.00 |
|
group | 0.050 | None | 1.000 | 2 | 0 | 2002 | 2017 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
group | 0.050 | None | 1.000 | 2 | 0 | 2004 | 2015 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.050 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.050 | None | 1.000 | 2 | 0 | 1995 | 2019 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
group | 0.050 | None | 0.800 | 1 | 0 | 1991 | 2010 | ||||||||
|
galectin 3 | 0.392 | 0.846 | 2.3E-05 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2008 |